Prof. Nicolas Girard is a leading thoracic oncologist and famous respiratory medicine expert, specializing in the treatment of lung cancer, neuroendocrine tumors, and thymic malignancies. As a top lung cancer specialist, he plays a pivotal role in shaping perioperative strategies, managing locally advanced thoracic cancers, and pioneering targeted therapies for oncogene-addicted tumors. Prof. Girard currently serves as the Head of the Curie-Montsouris Thorax Institute and Chair of the Medical Oncology Department at Institut Curie, Paris, while also holding an academic position as Professor of Respiratory Medicine at Versailles Saint-Quentin University. Recognized as the best thymic tumor doctor in France, his groundbreaking contributions to rare thoracic cancer research and clinical advancements in EGFR-mutant NSCLC treatment have earned him global recognition.
Prof. Nicolas Girard, a top oncologist in Paris, has extensive expertise in the diagnosis, treatment, and research of thoracic malignancies, particularly lung cancer, thymic tumors (thymomas and thymic carcinomas), and neuroendocrine tumors. As a famous expert in thoracic oncology, his work spans perioperative strategies, targeted therapies, and precision medicine for complex thoracic cancers. Recognized as the best lung cancer specialist in France, he plays a vital role in EURACAN (European Reference Network for Rare Cancers) and RYTHMIC (French National Network for Thymic Tumors), actively leading collaborative research projects to improve patient care and therapeutic advancements. As a leading thymic tumor doctor, he continues to drive innovation in the treatment of these rare cancers, ensuring that patients benefit from the latest medical breakthroughs.